Transient contribution of mast cells to pulmonary eosinophilia but not to hyper-responsiveness

Clinical and Experimental Allergy

Volumn 32, Issue 1, 2002, Pages 140-148

  Ogawa, K ^a   Kaminuma, O ^a   Kikkawa, H ^a   Nakata, A ^a   Asahina, M ^a   Egan, R W ^b   Akiyama, K ^c   Mori, A ^c  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^b MERCK RESEARCH LABORATORIES   (United States)

^c SAGAMIHARA NATIONAL HOSPITAL   (Japan)

Author keywords

Bronchial hyper responsiveness; CD4+ T cell; Cyclosporin A; Eosinophilic inflammation; IL 5; Mast cell

Indexed keywords

ACETYLCHOLINE; ANTIGEN; CYCLOSPORIN A; INTERLEUKIN 5 ANTIBODY; OKT 4; OVALBUMIN;

ANIMAL MODEL; ARTICLE; BRONCHUS HYPERREACTIVITY; BRONCHUS MUCOSA; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; IMMUNIZATION; INHALATION; LOEFFLER PNEUMONIA; LUNG LAVAGE; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY AIRFLOW;

ADMINISTRATION, INHALATION; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS; ANTIGENS, CD4; BRONCHI; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CELL MOVEMENT; CYCLOSPORINE; EOSINOPHILS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-5; MALE; MAST CELLS; MICE; MICE, INBRED STRAINS; PULMONARY EOSINOPHILIA; TIME FACTORS;

EID: 0036122623     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-0477.2001.01248.x     Document Type: Article

References (70)

1. T cells and eosinophils in the pathogenesis of asthma
2. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity
3. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma
4. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness
5. Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma
6. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage
7. Coordinate regulation of immune and inflammatory responses by T cell-derived lymphokines
8. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma
9. Recombinant human interleukin 5 is a selective activator of human eosinophil function
10. Interleukin-5, eosinophils, and disease
11. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma
12. Predominant TH2-1ike bronchoalveolar T-lymphocyte population in atopic asthma
13. + T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma
14. + T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A
15. Cellular and molecular mechanisms of IL-5 synthesis in atopic diseases: A study with allergen - Specific human helper T cells
16. T-cell-dependent accumulation of eosinophils in the lung and its inhibition by monoclonal anti-interleukin-5
17. + T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea
18. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia
19. Interleukin-4 is required for the induction of lung Th2 mucosal immunity
20. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization
21. Effects of chronic antiinterleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation
22. Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness
23. Successful transfer of late phase eosinophil infiltration in the lung by infusion of helper T cell clones
24. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores
25. Production of the haemopoiefic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation
26. Interleukin 4 is located to and released by human mast cells
27. Activated mast cells produce interleukin 13
28. Human lung mast cell IL-5 gene and protein expression: Temporal analysis of upregulation following IgE-mediated activation
29. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells
30. Mast cells enhance eosinophil survival in vitro: Role of TNF-α and granulocyte-macrophage colony-stimulating factor
31. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig)E and IgG1 in mice
32. Central role of immunoglobulin (Ig)E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: Inhibition by a non-anaphylactogenic anfi-IgE antibody
33. Mast cells modulate allergic pulmonary eosinophilia in mice
34. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model
35. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice
36. Attenuation of allergic airway inflammation in IL-4 deficient mice
37. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice
38. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma
39. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice
40. Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes
41. Antigen-induced airway hyperresponsiveness, pulmonary eosinophilia, and chemokine expression in B cell-deficient mice
42. Antibody against interleukin-5 prevents antigen-induced eosinophil infiltration and bronchial hyperreactivity in the guinea pig airways
43. Virgin T cells do not provide help for antigen-specific B cells in the absence of IL-4, IL-5, and IL-6
44. Relation between morphological and physiological events in lung studied by rapid freezing
45. Versuchsanordnung zu untersuchungen an der bronchialmuskulatur
46. T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged mice
47. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors
48. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
49. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins
50. + T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice
51. Induction of pulmonary allergic responses by antigen-specific Th2 cells
52. Evidence that cyclosporin A and dexamethasone inhibit allergic airway eosinophilic inflammation via suppression of interleukin-5 synthesis by T cells
53. Allergen-specific Thl cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation
54. + T cells
55. Cellular events in the bronchi in mild asthma and after bronchial provocation
56. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry
57. The immunosuppressant FK506 effectively inhibits expression of early T cell activation genes
58. The mechanism of action of cyclosporin A and FK506
59. + T cells is suppressed by FK506
60. Effects of cyclosporin A and dinactin on T-cell proliferation, interleukin-5 production, and murine pulmonary, inflammation
61. Effect of some immunosuppressors on allergic bronchial inflammation and airway hyperresponsiveness
62. Inhibition by the immunosuppressive agent FK-506 of antigen-induced airways eosinophilia and bronchial hyperreactivity in mice
63. Phenotype of cells expressing mRNA for TH2-type (interleukin-4 and interleukin-5) and THl-type (interleukin-2 and interferon-γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatics and normal control subjects
64. + T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics
65. T cells are the predominant source of interleukin-5 but not interleukin-4 mRNA expression in the lung of antigen-challenged allergic mice
66. Immunohistochemical detection of GM-CSF, IL-4 and IL-5 in a murine model of allergic bronchopulmonary aspergillosis
67. Mast cells as source of mutifunctional cytokines
68. Human lung mast cells release small amounts of interleukin-4 and tumor necrosis factor-alpha in response to stimulation by anti-IgE and stem cell factor
69. IL-3 does not affect the allergic airway responses and leukotriene production after allergen challenge in rats
70. The importance of leukotrienes in airway inflammation in a mouse model of asthma